No clinical trial has fixed meal timing around retatrutide injections
Tomas E, Habener JF (2010) Insulin-like actions of glucagon-like peptide-1: a dual receptor hypothesis
If you have doses remaining as the BUD approaches, use them according to schedule but be extra diligent about storage
In the subcutaneous semaglutide group, among those who did not discontinue ( n = 45), 44/45 individuals (98%) were escalated to the maximum dose of 1.0 mg, with only one (2%) remaining at 0.5 mg
Manufacturing Capacity and Supply Chain Investment: In a bid to avoid previous shortages of injectable GLP-1s, Eli Lilly has amassed a $1.5 billion pre-launch inventory of its oral weight loss drug orforglipron ahead of FDA decision expected in April 2026 [4]
Most people feel less hungry and may start to lose weight, though the dose usually starts low and steps up about every four weeks so your body adjusts and side effects stay manageable